A new technology transfer project, MabTHER, has been established to strengthen Serbia’s capacity to develop monoclonal therapeutic antibodies (Mab).
Read MoreJanuary 15, 2024


A new technology transfer project, MabTHER, has been established to strengthen Serbia’s capacity to develop monoclonal therapeutic antibodies (Mab).
Read More